Jones Gene P 4
4 · Vaughan Foods, Inc. · Filed Sep 16, 2011
Insider Transaction Report
Form 4
Jones Gene P
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2011-06-21+140,000→ 140,000 totalExercise: $0.38From: 2011-06-21Exp: 2021-06-21→ Common Stock (140,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2011-09-16−140,000→ 0 totalExercise: $0.38From: 2011-06-21Exp: 2021-06-21→ Common Stock (140,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2011-09-16−14,120→ 0 totalExercise: $0.69From: 2009-03-12Exp: 2019-03-12→ Common Stock (14,120 underlying) - Disposition to Issuer
Common stock
2011-09-16$1.58/sh−25,000$39,500→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2011-09-16−80,000→ 0 totalExercise: $0.69From: 2008-11-26Exp: 2018-11-26→ Common Stock (80,000 underlying)
Footnotes (4)
- [F1]The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person was or is, for the purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of Vaughan Foods, Inc. (the "Issuer") or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer;
- [F2]Pursuant to that certain Agreement and Plan of Merger, dated as of July 6, 2011, among the Issuer, Reser's Fine Foods, Inc. and Reser's Acquisition, Inc., at the effective time of the merger (the "Effective Time"), each share of Issuer common stock ("Common Stock") converted into the right to receive $1.58 in cash;
- [F3]Not applicable; and
- [F4]At the Effective Time, each outstanding option to purchase shares of Common Stock, whether vested or unvested, will be converted into the right to receive an amount equal to the excess of $1.58 over the exercise price of such option.